Sofinnova Investments’s CRISPR Therapeutics CRSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Hold
0
63
2023
Q3
Hold
0
56
2018
Q3
Hold
0
61
2018
Q2
Hold
0
61